Erie Doctrine, General Principles, and Running-Out the Clock
Patently O
MARCH 15, 2022
Sarepta Therapeutics, Inc. After a failed negotiation, Sarepta petitioned for Inter Partes Review of Nippon Shinyaku’s patents. Sarepta has now petitioned for en banc review: asking two procedural questions, including one on the Erie Doctrine. Webasto Sunroofs, Inc., Nippon Shinyaku Co. 2d 113 (Del.
79 
Let's personalize your content